Trials / Completed
CompletedNCT02322008
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,035 (actual)
- Sponsor
- Regionshospitalet Viborg, Skive · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Can genetic markers be used to predict anti-TNF response? A cohort was established to identify SNPs associated with anti-TNF therapy in patients with inflammatory bowel disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | infliximab and adalimumab | In this retrospective, observational study, no interventions were undertaken by the researchers. |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2014-12-22
- Last updated
- 2014-12-23
Source: ClinicalTrials.gov record NCT02322008. Inclusion in this directory is not an endorsement.